1.45
4.61%
-0.07
Salarius Pharmaceuticals Inc (SLRX) Stock Split History
Salarius Pharmaceuticals Inc has split its stock 3 times since its initial public offering (IPO). The first stock split occurred on July 22, 2019 with the ratio of 1-for-25, meaning that for 25 shares of SLRX owned pre-split, shareholders then owned 1 share. 2 more splits have been implemented since then. The most recent stock split took place on June 17, 2024 on a 1-for-8 basis.
These splits have increased SLRX stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Salarius Pharmaceuticals Inc's total market capitalization.
For more detailed information of Salarius Pharmaceuticals Inc's stock splits, view the table below:
These splits have increased SLRX stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Salarius Pharmaceuticals Inc's total market capitalization.
For more detailed information of Salarius Pharmaceuticals Inc's stock splits, view the table below:
SLRX stock split list
Date | Split Ratio |
---|---|
2024-06-17 | 1 - for - 8 |
2022-10-17 | 1 - for - 25 |
2019-07-22 | 1 - for - 25 |
Will Salarius Pharmaceuticals Inc Stock Split in 2024?
The answer will depend on the decisions of the company's managers and market volatility. Salarius Pharmaceuticals Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when SLRX stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Salarius Pharmaceuticals Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
Stock Splits of Industry Leaders
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):